Research Grade Rovelizumab
Product Sizes
1 mg
£575.00
DHC13102-1MG
5 mg
£1565.00
DHC13102-5MG
25 mg
£4027.00
DHC13102-25MG
About this Product
- SKU:
- DHC13102
- Additional Names:
- Bispecific, Hu23F2G, 23F2G, CAS: 339086-79-2
- Buffer:
- 0.01M PBS, pH 7.4.
- translate.label.attr.clone:
- Rovelizumab
- Clonality:
- Recombinant Monoclonal
- Host:
- Human
- Immunogen:
- Complement receptor C3 subunit beta, Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta, Integrin beta-2, MFI7, CD18, ITGB2, CD11A, Leukocyte function-associated molecule 1 alpha chain, Leukocyte adhesion glycoprotein LFA-1 alpha chain, LFA-1A, CD11 antigen-like family member A, CD11a, ITGAL, Integrin alpha-L, CR-3 alpha chain, Cell surface glycoprotein MAC-1 subunit alpha, Leukocyte adhesion receptor MO1, ITGAM, CD11b, CD11 antigen-like family member B, Integrin alpha-M, CR3A, CD11B, Neutrophil adherence receptor
- Isotype:
- IgG4
- Physical State:
- Liquid
- Purity:
- >95%
- Purification:
- Protein A/G purified from cell culture supernatant.
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- -20[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Supplier:
- AntibodySystem
- Type:
- Antibody: Recombinant Antibodies
